|

Use of Artificial Intelligence-Guided Echocardiography to assIst cardiovascuLar Patient managEment

RECRUITINGN/ASponsored by Baker Heart and Diabetes Institute
Actively Recruiting
PhaseN/A
SponsorBaker Heart and Diabetes Institute
Started2023-02-24
Est. completion2026-06-30
Eligibility
Age45 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05558605

Summary

Heart Failure and valvular heart disease are disproportionate problems in rural and remote Australia (RRA). Echocardiography is the best imaging investigation, and essential for management, but access to this essential test shows huge geographic variations, primarily because of dependence on expert acquisition. This trial seeks to demonstrate the effectiveness of artificial intelligence-based echocardiography for triage and management of patients with known or suspected heart disease in RRA.

Eligibility

Age: 45 Years+Healthy volunteers accepted
Inclusion Criteria:

* Age \>45 years
* eligible for Medicare
* exercise intolerance or cardiovascular (CV) risk factors

Exclusion Criteria:

* Known HF or HVD
* situations where cardio-protection is already indicated (eg. known CAD)
* comorbid conditions with life expectancy \<2 years
* inability to provide written informed consent

Conditions3

Heart DiseaseHeart FailureValve Heart Disease

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.